Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
185 studies found for:    "Poliomyelitis"
Show Display Options
Rank Status Study
21 Completed Polio End-game Strategies - Poliovirus Type 2 Challenge Study
Condition: Poliomyelitis
Interventions: Biological: IPV;   Biological: bOPV;   Biological: bOPV and IPV;   Biological: bOPV and IPV and IPV2;   Biological: tOPV
22 Completed Immunogenicity and Safety of 3 Adjuvated Reduced Dose Inactivated Polio Vaccines (IPV-Al SSI) and Non-adjuvated Full Dose IPV SSI, Given as Primary Vaccinations to Infants at 6, 10 and 14 Weeks of Age
Condition: Poliomyelitis
Interventions: Biological: Primary series of immunisation comprised by 3 vaccinations IPV-Al SSI;   Biological: IPV Vaccine SSI
23 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
24 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
25 Completed Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
Conditions: Acellular Pertussis;   Poliomyelitis;   Diphtheria;   Tetanus
Intervention: Biological: BoostrixTM Polio
26 Completed Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
Conditions: Acellular Pertussis;   Tetanus;   Diphtheria;   Poliomyelitis
Interventions: Biological: Boostrix Polio™ 711866;   Biological: Priorix Tetra TM 208136;   Biological: Tetravac TM
27 Completed Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
Conditions: Acellular Pertussis;   Poliomyelitis;   Tetanus;   Diphtheria
Interventions: Biological: Boostrix PolioTM;   Biological: RepevaxTM;   Biological: PriorixTM
28 Completed Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine
Conditions: Hepatitis B;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: DTPa-HBV-IPV/Hib (Infanrix hexa™);   Biological: OPV
29 Completed Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine
Condition: Poliomyelitis
Intervention: Biological: poliovirus vaccine
30 Completed Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
31 Completed Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine (IMOVAX)
32 Completed Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated types 1, 2, and 3 poliovirus, D antigens
33 Completed Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
34 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
35 Completed Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
36 Completed Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
Condition: Poliomyelitis
Interventions: Drug: IPV;   Drug: Sabin-IPV;   Drug: Adjuvanted Sabin-IPV
37 Completed Diarrhea and Bivalent Oral Polio Vaccine Immunity
Conditions: Seroimmunity;   Diarrhea;   Polio
Intervention: Biological: bivalent oral polio vaccine
38 Completed Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
Conditions: Poliomyelitis;   Diphtheria;   Pertussis;   Tetanus
Intervention: Biological: Boostrix-Polio
39 Completed Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
Condition: Post Polio Syndrome, PPS
Intervention: Drug: Xepol
40 Completed Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
Conditions: Poliomyelitis;   Polio
Intervention: Biological: Inactive Poliovirus Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years